Application of liquid biopsy-based targeted capture sequencing analysis to improve the precision treatment of non-small cell lung cancer by tyrosine kinase inhibitors

BACKGROUND: Targeted therapy of patients with non-small cell lung cancer (NSCLC) who harbour sensitising mutations by tyrosine kinase inhibitors (TKIs) has been found more effective than traditional chemotherapies. However, target genes status (eg, epidermal growth factor receptor (EGFR) TKIs sensit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lei, Coffin, John, Formenti, Kim, Chu, Quincy, Izevbaye, Iyare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804681/
https://www.ncbi.nlm.nih.gov/pubmed/35091437
http://dx.doi.org/10.1136/bmjresp-2021-001154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804681/
https://www.ncbi.nlm.nih.gov/pubmed/35091437
http://dx.doi.org/10.1136/bmjresp-2021-001154

Ejemplares similares